Bruker and Carestream Health have signed a contract which will enable Bruker to acquire the pre-clinical in-vivo imaging equipment and associated assets from Carestream’s Molecular Imaging enterprise.
Bruker is a supplier of high-performance scientific equipment and solutions for materials and molecular research, and also for applied and industrial studies. Carestream Health is a global provider of x-ray films and digital x-ray setups for non-destructive imaging; sophisticated products for the precision films and electronics markets; and medical and dental imaging systems and healthcare IT solutions. Financial conditions of the contract are being kept under wraps. As per the conditions of the contract, most of the Carestream pre-clinical in-vivo imaging personnel will be given an option to be a part of Bruker. The contract will be concluded in the coming weeks.
Carestream will hold on to the remaining assets of its Molecular Imaging enterprise, inclusive of its life-science x-ray films merchandise assortment as well as its Gel Logic and Image Station in-vitro imaging equipment merchandise portfolio. Carestream will continue to its life-science x-ray film business, and will go on providing assistance to its in-vitro goods customers with spare parts and services. Its Gel Logic and Image Station in-vitro merchandise will no longer be produced.
The President of BrukerBioSpin, Dr Werner Mass stated that the organization is pleased with the addition of Carestream in-vivo imaging systems to Bruker’s pre-clinical imaging merchandise portfolio. He added that Carestream’s optical molecular imaging equipment will supplement Bruker’s other pre-clinical solutions, which currently include magnetic particle imaging (MPI), x-ray micro-computed chromatography (microCT) and magnetic resonance imaging (MRI). He also extended a warm welcome to Carestream employees who will be a part of Bruker and looked forward to their quality services.